NCT05146206

Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments for Allergic Rhinitis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 426 (actual)
• Sponsor: Community and Patient Preference Research Pty Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The study seeks to understand patients' satisfaction and importance of treatment attributes for Allergic Rhinitis nasal sprays from two brands (RYALTRIS® vs. DYMISTA®).

Detailed description

The study seeks to understand patients' satisfaction and importance of treatment attributes for Allergic Rhinitis nasal sprays from two brands (RYALTRIS® vs. DYMISTA®). To directly compare patient satisfaction with 2 different Allergic Rhinitis nasal sprays, an observational, cross-sectional study design with 2 independent samples was chosen. Participants will complete an online survey involving a Best-Worst scaling (BWS) task to determine satisfaction and importance index for sensory attributes. The suggested treatment attributes are informed by a range of previous studies, including those conducted by Meltzer et al 2005 and Price et al 2020, and methodology from CaPPRe's own work in developing indices for importance and satisfaction of treatment attributes using BWS.

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
OTHER	Observational	In this observational study, participants initated on RYALTRIS/DYMISTA nasal spray will complete a cross-sectional online survey that includes a Best-Worst Scaling task to capture their satisfaction and importance of various treatment attributes.

Timeline

• Start date: 2021-11-08
• Primary completion: 2022-02-27
• Completion: 2022-02-27
• First posted: 2021-12-06
• Last updated: 2024-04-12
• Results posted: 2024-04-12

Locations

1 site across 1 country: Australia